GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 180 Life Sciences Corp (NAS:ATNFW) » Definitions » Price-to-Tangible-Book

180 Life Sciences (180 Life Sciences) Price-to-Tangible-Book : (As of May. 29, 2024)


View and export this data going back to 2017. Start your Free Trial

What is 180 Life Sciences Price-to-Tangible-Book?

As of today (2024-05-29), 180 Life Sciences's share price is $0.0092. 180 Life Sciences's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $0.00. Hence, 180 Life Sciences's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for 180 Life Sciences's Price-to-Tangible-Book or its related term are showing as below:

During the past 5 years, 180 Life Sciences's highest Price to Tangible Book Ratio was 20.42. The lowest was 20.42. And the median was 20.42.

ATNFW's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.79
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, 180 Life Sciences's share price is $0.0092. 180 Life Sciences's Book Value per Sharefor the quarter that ended in Mar. 2024 was $0.00. Hence, 180 Life Sciences's P/B Ratio of today is .


180 Life Sciences Price-to-Tangible-Book Historical Data

The historical data trend for 180 Life Sciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

180 Life Sciences Price-to-Tangible-Book Chart

180 Life Sciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - - - -

180 Life Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of 180 Life Sciences's Price-to-Tangible-Book

For the Biotechnology subindustry, 180 Life Sciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


180 Life Sciences's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 180 Life Sciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where 180 Life Sciences's Price-to-Tangible-Book falls into.



180 Life Sciences Price-to-Tangible-Book Calculation

180 Life Sciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.0092/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


180 Life Sciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of 180 Life Sciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


180 Life Sciences (180 Life Sciences) Business Description

Traded in Other Exchanges
Address
3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA, USA, 94306
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.